Edition:
United States

Harbin Pharmaceutical Group Co Ltd (600664.SS)

600664.SS on Shanghai Stock Exchange

5.81CNY
--
Change (% chg)

-- (--)
Prev Close
¥5.81
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
¥8.68
52-wk Low
¥5.24

Chart for

About

HARBIN PHARMACEUTICAL GROUP CO., LTD. is a China-based company, principally engaged in the manufacture and distribution of pharmaceuticals. The Company's major products include chemical raw medicines, antibiotics, Chinese medicines, chemical drugs, over-the-counter (OTC) medicines, healthcare products, biological engineering,... (more)

Overall

Beta: 0.78
Market Cap(Mil.): ¥14,786.18
Shares Outstanding(Mil.): 2,544.95
Dividend: 0.50
Yield (%): 8.61

Financials

  Industry Sector
P/E (TTM): -- 31.22 16.52
EPS (TTM): -- -- --
ROI: -- 14.09 36.19
ROE: -- 15.56 17.38

China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.

Feb 14 2018

China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG, Feb 14 China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.

Feb 13 2018

BRIEF-GNC Holdings Says On Deal Termination Co to Pay Termination Fee Of Either $10 Mln Or $18 Mln To Harbin Pharmaceutical

* GNC HOLDINGS - ON DEAL TERMINATION UNDER CIRCUMSTANCES, CO WILL PAY FEE OF EITHER $10 MILLION OR $18 MILLION TO HARBIN PHARMACEUTICAL GROUP - SEC FILING Source text: (http://bit.ly/2o4g6KY) Further company coverage:

Feb 13 2018

Earnings vs. Estimates